PML Update: May 2013

"Biogen-Idec the company that helped develop and market natalizumab are concerned that my monthly PML update is too complicated for MSers to understand. I have therefore tried to simplify the slide deck. This is a work in progress and will need to be improved on when I have some spare time. Any feedback on its contents would therefore be very helpful. For one it is too long."

As of 6th May 2013 there have been 359 confirmed cases of natalizumab-associated PML.



"I am aware that a lot of my professional colleagues have begun to use this blog as an easy way to access the latest PML data. I will therefore make the 'for professionals only' slide deck from Biogen-Idec available as well on a monthly basis for healthcare professionals via the blog."



"Apologies about being so patronising."

CoI: multiple

Labels: , , , , ,